A Study to Assess the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of 2-Week Treatment With Inhaled AZD7594 in Adolescents (12 to 17 Years) With Asthma
Clinical trial NCT03976869 · COMPLETED
Trial details
- NCT number
- NCT03976869
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-24
- Primary completion
- 2020-07-09
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.